Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
eMedicine - Septic Arthritis : Article by

Quick Find
Authors & Editors
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
References




Patient Education
Arthritis Center

Bites and Stings Center

Knee Pain Introduction

Types of Knee Pain

Ticks Overview




Author: John L Brusch, MD, FACP, Assistant Professor of Medicine, Harvard Medical School; Consulting Staff, Department of Medicine and Infectious Disease Service, Cambridge Health Alliance

John L Brusch is a member of the following medical societies: American College of Physicians and Infectious Diseases Society of America

Editors: Maria D Mileno, MD, Assistant Professor, Department of Internal Medicine, Division of Infectious Diseases, Brown University; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Aaron Glatt, MD, Professor of Clinical Medicine, New York Medical College; Chief Medical Officer, Departments of Medicine and Infectious Diseases, New Island Hospital; Eleftherios Mylonakis, MD, Clinical and Research Fellow, Department of Internal Medicine, Division of Infectious Diseases, Massachusetts General Hospital; Burke A Cunha, MD, Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital

Author and Editor Disclosure

Synonyms and related keywords: reactive arthritis, inflammatory arthritis, bacterial septic arthritides, bacterial septic arthritis, suppurative arthritis, Neisseria gonorrhoeae, N gonorrhoeae, Staphylococcus aureus, S aureus, Streptococcus viridans, S viridans, Streptococcus pneumoniae, S pneumoniae, group B streptococci, crystalline arthritis, Lyme disease, Lyme arthritis, prosthetic joint infections, PJI, rheumatoid arthritis

Background

Infective arthritis may represent a direct invasion of joint space by various microorganisms, including bacteria, viruses, mycobacteria, and fungi. Reactive arthritis, a sterile inflammatory process, may be the consequence of an infectious process located elsewhere in the body. Although any infectious agent may cause arthritis, bacterial pathogens are the most significant because of their rapidly destructive nature. For this reason, the current discussion concentrates on bacterial septic arthritides. Failure to recognize and to appropriately treat septic arthritis results in significant rates of morbidity and may even lead to death.

Because of the increasing use of prosthetic joints, infection associated with these devices may be the most common and challenging type of septic arthritis encountered by most clinicians.

Approximately 20,000 cases of suppurative arthritis occur in the United States each year. The 2 major classes of bacterial/suppurative arthritis are gonococcal and nongonococcal. Overall, although Neisseria gonorrhoeae remains the most frequent pathogen (75% of cases) among younger sexually active individuals, Staphylococcus aureus is the most common cause of the vast majority of cases of acute bacterial arthritis in adults and in children older than 2 years. This pathogen is the cause in 80% of infected joints affected by rheumatoid arthritis. Streptococcal species, such as Streptococcus viridans, Streptococcus pneumoniae, and group B streptococci, account for 20% of cases. Aerobic gram-negative rods are involved in 20-25% of cases. Most of these infections occur in people who are very young, who are very old, who are immunosuppressed, and who abuse intravenous drugs.

Polymicrobial joint infections (5-10% of cases) and infection with anaerobic organisms (5% of cases) usually are a consequence of trauma or of abdominal infection. The organism of Lyme disease (ie, Borrelia burgdorferi), a large variety of viruses (eg, HIV, lymphocytic choriomeningitis virus, hepatitis B virus, rubella virus), mycobacteria, fungi (eg, Histoplasma species, Sporothrix schenckii, Coccidioides immitis, Blastomyces species), and other pathogens may produce nonsuppurative joint infection.

Three major types of prosthetic joint infections (PJIs) exist: those that occur early, within 3 months of implantation; those that are delayed, within 3-24 months of implantation; and those that occur later than 24 months following the implantation. Most cases of early PJI are caused by S aureus, while delayed infections are due to coagulase-negative Staphylococcus aureus (CONS) and gram-negative aerobes. Both of these types are acquired in the operating room. Late cases of PJI are secondary to hematogenous spread from various infectious foci.

Pathophysiology

Organisms may invade the joint by direct inoculation, by contiguous spread from infected periarticular tissue, or via the bloodstream (the most common route).

The normal joint has several protective components. Healthy synovial cells possess significant phagocytic activity, and synovial fluid normally has significant bactericidal activity. Rheumatoid arthritis and systemic lupus erythematosus lessen the defensive functions of synovial fluid and decrease chemotaxis and phagocytic function of polymorphonuclear leukocytes.

Previously damaged joints, especially those damaged by rheumatoid arthritis, are the most susceptible to infection. The synovial membranes of these joints exhibit neovascularization and increased adhesion factors; both conditions increase the chance of bacteremia, resulting in a joint infection. Some microorganisms have properties that promote their tropism to the synovium. S aureus readily binds to articular sialoprotein, fibronectin collage, elastin, hyaluronic acid, and prosthetic material by means of specific tissue adhesion factors (microbial surface components recognizing adhesive matrix molecules [MSCRAMMs]). In adults, the arteriolar anastomosis between the epiphysis and the synovium permits the spread of osteomyelitis into the joint space.

The major consequence of bacterial invasion is damage to articular cartilage. This may be due to the particular organism's pathological properties, such as the chondrocyte proteases of S aureus, as well as to the host's polymorphonuclear leukocytes response. The cells stimulate synthesis of cytokines and other inflammatory products, resulting in the hydrolysis of essential collagen and proteoglycans. Infection with N gonorrhoeae induces a relatively mild influx of white blood cells into the joint, which explains, in part, the minimal joint destruction observed with infection with this organism compared to destruction associated with S aureus infection.

As the destructive process continues, pannus formation begins and cartilage erosion occurs at the lateral margins of the joint. Large effusions, which can occur in infections of the hip joint, impair the blood supply and result in aseptic necrosis of bone. These destructive processes are well advanced as early as 3 days into the course of untreated infection.

Viral infections may cause direct invasion (rubella) or production of antigen/antibody complexes. Such immunological mechanisms occur in infections with hepatitis B, parvorvirus B19, and lymphocytic choriomeningitis viruses.

Reactive, or postexposure, arthritis is observed more commonly in patients with human lymphocyte antigen B27 (HLA-B27) histocompatibility antigens. Although various infections can cause reactive arthritis, gastrointestinal processes are by far the most common. Gastrointestinal pathogens associated with reactive arthritis include the following:

  • Salmonella enteritidis
  • Salmonella typhimurium
  • Yersinia enterocolitica
  • Campylobacter jejuni
  • Clostridium difficile
  • Shigella sonnei
  • Entamoeba histolytica
  • Cryptosporidium

Genitourinary infections, especially those due to Chlamydia trachomatis, are the second most common cause of reactive arthritis. The arthritis of Lyme disease usually results from immunological mechanisms, with a minority of cases due to direct invasion by an organism.

PJIs may be a consequence of local infection, such as intraoperative contamination (60-80% of cases), or of bacteremias (20-40% of cases). The latter type may be spontaneous (ie, gingival disease) or secondary to various manipulations. Delayed wound healing is a major factor behind early PJI. Until the fascia has healed, the usual tissue barriers to infection of the implant are not present. Eventually, the implanted hardware becomes less susceptible to infection by hematogenous spread because the pseudocapsule develops around it.

The biofilm of CONS protects the pathogen from the host's defenses, as well as from various antibiotics. Polymethylmethacrylate cement inhibits white blood cell and complement function.

Overall, the most common organisms of PJIs are CONS (22% of cases) and S aureus (22% of cases). Enteric gram-negative organisms account for 25% of isolates. Streptococci, including S viridans, enterococci, and the beta-hemolytic streptococci, cause 21% of cases. Anaerobes are isolated from 10% of patients.

Frequency

United States

Approximately 20,000 cases of suppurative arthritis occur each year in the United States (7.8 cases per 100,000 person-years). The incidence of arthritis of disseminated gonococcal infection is 2.8 cases per 100,000 person-years. Suppurative arthritis is becoming increasingly common among people who are immunosuppressed and elderly persons; these are groups who suffer from various comorbid disease states. The incidence of PJI among all prosthesis recipients ranges from 2-10%.

International

The incidence of septic arthritis in Europe is identical to that in the United States.

Mortality/Morbidity

The primary morbidity of infective arthritis is significant dysfunction of the joint, even if treated properly. The mortality rate primarily depends on the causative organism. N gonorrhoeae has an extremely low mortality rate, while that of S aureus can approach 50%.

Race

No racial predisposition is recognized.

Sex

Fifty-six percent of patients are male.

Age

Forty-five percent of people with septic arthritis are older than 65 years.



History

Because joint infections are uncommon, be especially attentive to features of the patient's history that may indicate an infectious process instead of a primary rheumatologic or orthopedic process.

  • Pay attention to the following symptoms:
    • Acuteness of onset of the joint pain
    • Whether the pain is superimposed on chronic pain
    • Previous history of joint disease or trauma, whether accidental or iatrogenic (eg, infection complicates 0.4% of arthrocenteses)
    • Whether the process is monoarticular or polyarticular and which joints are involved
    • The presence of extra-articular symptoms
    • Whether the patient has had vascular invasion due to catheterizations or intravenous drug abuse
  • Obtain a thorough history regarding the possible presence of sexually transmitted diseases (STDs) or exposure to ticks (Lyme disease). The increase of group B streptococcal joint infections is associated with the increased prevalence of diabetes and increasing life expectancy.
  • A number of conditions that have an adverse effect on the host's defenses (eg, liver disease, diabetes mellitus, lymphoma, solid tumors, complement deficiencies [C7, C8], immunosuppressive drugs, hypogammaglobulinemia) are noted increasingly in patients with septic arthritis. Determine the possible contribution of these diseases to the clinical presentation.
  • The most important historical feature is the existence of underlying joint disease, especially rheumatoid arthritis. In addition, the possibility of recent injury to the joint or penetrating or blunt trauma must be explored. Ask the patient about needle aspiration of the joint or injections of corticosteroids into the joint. Elicit a history of diarrheal disease. Patients with an infected joint typically present with the triad of fever (40-60% of cases), pain (75% of cases), and impaired range of motion. These symptoms may evolve over a few days to a few weeks. Fever usually is low grade ( <102°F), with rigors present in only 20% of cases. Spiking fevers and chills are much more common with crystalline arthritis.
  • Months after the onset of infection, 60% of patients with untreated Lyme disease develop swelling and pain, chiefly affecting the large joints. Usually, Lyme disease affects 1-2 joints at a time, with the knee involved most commonly. The distinguishing pattern is attacks extending from a few weeks to months and separated by periods of complete remission. The rate of recurrence lessens by about 15% per year. A small percentage of individuals develop chronic arthritis (ie, inflammation of a joint lasting ³1 y). This type of relapsing course almost always precedes the chronic stage of Lyme arthritis.
  • Compared with patients with infections of native joints, most patients with PJI exhibit a prolonged low-grade course with gradually increasing pain.
    • Usually, no significant fever or swelling occurs (delayed PJI). However, individuals with early PJI present with an acute illness characterized by high-grade fever, focal swelling, and redness. Cellulitis and draining sinus tracts often develop.
    • Because late PJI is usually secondary to bacteremia, the clinical picture is often dominated by the source of the bloodstream infection.
    • The nature of the invading organism, the type of tissue infected, and the route of infection determine presentation. Thus, a high index of suspicion is needed for identification of bacteremic and delayed PJI. Because of its many pathogenic mechanisms, S aureus is usually associated with a fulminant course, as opposed to the indolent course of CONS that dominates delayed PJI. Relatively devitalized tissues (eg, wound hematomas) are conducive to rapid bacterial replication and a more acute course. Bacteremic spread allows infection with fewer organisms and leads to a more muted course.
  • Reactive arthritis usually begins several weeks after the underlying infection has resolved. Few concurrent systemic symptoms occur.
  • Symptoms of tuberculous arthritis are quite indolent; the diagnosis may be delayed for several years. Usually, the purified protein derivative (PPD) results are negative, and no signs, past or present, of pulmonary tuberculous exist.

    Table 1. Clinical Features of Viral Infective Arthritis

    VirusClinical Features of Viral Infective Arthritis
    Parvovirus B19Occurs in adult women with erythema infectiosum, often an itchy rash
    Hepatitis AMuscle aches and rash in 10% of cases
    Hepatitis BOnset in the preicteric phase
    Usually resolves as jaundice develops
    Chronic arthritis possible in patients with chronic hepatitis B infection
    Hepatitis CHistory similar to hepatitis B joint infection
    Rubella (natural infection and vaccine related)Onset possible before, during, or after the appearance of the rash
    Usually resolves in a few weeks
    May recur and, more commonly, may persist
    HIV (2 types occur, both with noninflammatory sterile joint fluid)Develops over several days and severe knee or ankle pain is characteristic
    Excellent response to nonsteroidal anti-inflammatory agents
    Sudden onset of severe pain in the shoulders and elbows, closely resembling an acute gouty attack
    Opiates often necessary to control pain
    MumpsOccurs in adult men 2 weeks after the presentation of parotitis

Physical

The most commonly involved joint is the knee (50% of cases), followed by the hip (20%), shoulder (8%), ankle (7%), and wrists (7%). The elbow, interphalangeal, sternoclavicular, and sacroiliac joints each make up 1-4% of cases. A thorough inspection of all joints for signs of erythema, swelling (90% of cases), warmth, and tenderness is essential for diagnosing infection. Infected joints usually exhibit an obvious effusion, which is associated with marked limitation of both active and passive ranges of motion. Frequently, these findings are apparent but may be diminished or poorly localized in cases of infection of the spine, hip, and shoulder joints.

Signs and symptoms of infection may be muted in people who are elderly, who are immunocompromised (especially those with rheumatoid arthritis), and who abuse intravenous drugs.

  • The pattern of joint involvement is an extremely important diagnostic feature. Of cases of nongonococcal suppurative arthritis, 85-90% are monoarticular. If the disease affects more than one joint, then S aureus most commonly is implicated. Polyarticular arthritis usually is observed in gonococcal disease, various viral infections, Lyme disease, reactive arthritis, and various noninfectious processes.
  • Group B streptococci most commonly infect the sacroiliac and sternoclavicular joints.
  • Gonococcal musculoskeletal involvement may present in one of two ways.
    • Fever, arthralgias of multiple joints, and multiple skin lesions (dermatitis-arthritis syndrome) characterize disease that develops soon after the gonococcus disseminates from the cervix, urethra, or pharynx. Usually, this disease exhibits no clinical direct joint findings, but the process is one of tenosynovitis of asymmetric distribution. Typically, hand joints are involved most, as well as those of the knee, wrist, ankle, and elbow. Skin lesions are multiple but seldom number more than 12, while lesions from meningococcemia may number more than 100. The lesions evolve over a few days from papular to pustular or vesicular to necrotic. This course may recur for several months. Findings on cultures of blood and mucosal surfaces often are positive; findings on cultures of joint fluid usually are negative. Sixty percent of disseminated gonococcal infections are of this type.
    • Monoarticular arthritis without associated systemic symptoms, tenosynovitis, or skin lesions characterizes disease that begins later after gonococcal dissemination than does dermatitis arthritis syndrome. Dermatitis-arthritis syndrome may or may not precede this phase. In a joint infected by the Lyme organism, swelling may be disproportionate to the level of pain. Baker cysts are a frequent feature of this type of infectious arthritis. Because the pain of an infected hip joint may not be localized directly and swelling of the joint is inconspicuous, perform specific maneuvers, such as the Fabere maneuver. Infection of the sacroiliac joint often presents as buttock, hip, or anterior thigh pain. Direct pressure usually elicits tenderness in the joint. Alternatively, hyperextension of the hip and leg while the patient is lying down (ie, Gaenslen maneuver) elicits pain in a suppurative sacroiliac joint.
  • Septic bursitis most commonly involves the olecranon and prepatellar bursae. Swelling and pain are present. However, an infected bursa does not limit the range of motion of the underlying joint the way an actual joint infection does.
  • Physical findings usually are minimal in an infection of the prosthetic joint, and swelling usually is slight. The most distinctive finding is a draining sinus presumed to originate in the underlying infected prosthetic joint.
  • Most cases of reactive arthritis involve a few large joints in an asymmetric fashion.
  • Viral arthritis usually exhibits symmetric involvement of the smaller joints, especially the hands, with a concurrent rash.
  • The joints of tuberculous arthritis can appear to be boggy on palpation.

Causes

Other distinctive host and/or situation-pathogen associations have been described, including Pasteurella multocida, Capnocytophaga species (dog and cat bites), Eikenella corrodens, anaerobes (especially Fusobacterium nucleatum and streptococcal species [human bites]), Aeromonas hydrophila (myelogenous leukemia), S aureus, CONS, gram-negative bacteria (prosthetic joints), Pseudomonas aeruginosa, S aureus, Serratia species, Candida species (particularly common in persons who abuse intravenous drugs), Mycobacterium marinum (water exposure), S schenckii (gardening), and S pneumoniae (sickle cell anemia). Unlike osteomyelitis, Salmonella species are not associated with the septic arthritis of sickle cell anemia. Ten to 30% of patients with brucellosis have lumbosacral spine involvement.



Other Problems to be Considered

Primary rheumatological disorders - Vasculitis, crystalline arthritides
Drug-induced arthritis
Reactive arthritis - Postinfectious diarrhea syndrome, postmeningococcal and postgonococcal arthritis, arthritis of intrinsic bowel disease



Lab Studies

  • Characterization of the synovial fluid by means of its leukocyte count, appearance on Gram stain, polarizing microscopy examination, and culture of the fluid is the most rewarding approach in evaluating a potentially infected joint. Additional stains and/or cultures should be obtained depending on the differential diagnoses considered.
  • Culture of the synovial fluid or of synovial tissue itself is the only definitive method of diagnosing infective arthritis. However, therapeutic decisions cannot be delayed until results of the culture are available. An approach to rapid evaluation of an acutely inflamed joint is to screen the fluid for crystals by polarizing microscopy and for organisms by Gram stain. If crystals are present and the Gram stain findings are negative, treat the patient for crystal-associated arthritis. An exception to this would be the presence of significant risk factors for infection (eg, the focus of infection lies somewhere that could lead to bacteremia, such as pneumonia or pyelonephritis).
  • If microscopy demonstrates no crystals, treat the patient for presumed infection even if the Gram stain findings are negative. The Gram stain is less than 60% sensitive for detection of bacteria in synovial fluid. Always send the fluid for culture, regardless of the result of the screening evaluation. A joint damaged by gout or pseudogout is prone to be infected. Culture of synovial tissue is indicated primarily to detect mycobacteria or fungi.
  • If the patient's condition does not improve significantly after 5 days, the joint must be reaspirated and examined. Most septic joints have a white count greater than 50,000, with more than 75% polymorphonuclear leukocytes. However, various sterile inflammatory processes may exhibit the same cellular profile.
  • Findings from examination of the synovial fluid in Lyme arthritis are similar to those found in infection caused by any other type of bacterium. Positive serology results (ie, antibody measurements, Western blot, polymerase chain reaction [PCR] for Lyme disease) do not establish the diagnosis of Lyme arthritis. A positive result on any of these tests simply indicates that the patient has encountered B burgdorferi; a positive result does not necessarily establish a connection between the patient's musculoskeletal symptoms and Lyme disease.
  • Alterations in the glucose and protein concentration of the synovial fluid are nonspecific; their measurement should not be performed routinely.
  • Obtain at least 2 sets of blood cultures to rule out bacteremic origin of the septic joint.
  • In the setting of possible gonococcal infection, obtaining cultures from the patient's rectum, cervix, urethra, and pharynx and from any skin lesions is most helpful. Immediate plating of the joint fluid directly onto appropriate media and/or rapid delivery of the specimen to the laboratory for appropriate plating and culturing are of benefit in improving the relatively low yield.
  • PCR holds promise for detection of bacterial DNA in joint fluid and synovial tissue. PCR has led to diagnosis of infective arthritis due to Yersinia species, B burgdorferi, Chlamydia species, N gonorrhoeae, and Ureaplasma species. Caveats about this approach are raised because it cannot be used to distinguish between live and dead organisms and it is susceptible to contamination.
  • Silver stains can be used to detect organisms in 5% of cases of Lyme arthritis.
  • Evaluation of a possibly infected prosthetic joint is similar to that of a natural joint. The presence of leukocytes in the aspirated fluid is variable. Because many of the potential pathogens also are classic contaminating organisms (eg, CONS, Propionibacterium, Corynebacterium), repeat aspirates often are required to confirm the diagnosis. Often, diagnostic imaging studies are needed to determine the significance of a given culture.
  • The synovial fluid of reactive arthritis demonstrates few signs of inflammation. PCR may reveal DNA of the purported causative organism.
  • The synovial fluid of a joint infected with Mycobacterium tuberculosis shows marked leukocytosis. Findings on acid-fast stains usually are negative. Culture results are positive in 80% of cases. Culture results of synovial biopsies are positive in 94% of specimens.
  • The fluid of an infected bursa closely resembles that of a bacterial joint infection.
  • An elevated sedimentation rate or C-reactive protein is useful in following response to therapy, as well as in detecting an acute process in chronically affected joints.
  • Measurement of serum uric acid levels cannot be used to establish or negate the diagnosis of uric acid arthropathy. Values may range widely during an acute attack.
  • Appropriate serological tests for the diagnosis of various vasculitides or rheumatological disorders often are indicated.

Imaging Studies

  • Plain radiographs are of some limited value in evaluating a joint for infection.
    • Periarticular soft tissue swelling is the most common finding. Radiographs are most useful in ruling out underlying osteomyelitis or periarticular osteomyelitis resulting from the joint infection itself.
    • The linear deposition of calcium pyrophosphate can be detected on a plain radiograph. The radiographic findings of reactive arthritis usually are limited to those of soft tissue swelling. Periarticular osteoporosis may be detected.
  • Ultrasonography may be used to diagnose effusions in chronically distorted joints (secondary to trauma or rheumatoid arthritis).
  • CT scans and MRIs are more sensitive for distinguishing osteomyelitis, periarticular abscesses, and joint effusions. The information gained usually does not justify the increased cost; however, these tests are most helpful in patients with sacroiliac or sternoclavicular joint infection to rule out extension into the mediastinum or pelvis. MRI is preferred because of its greater ability to image soft tissue.
  • Radionuclide scans (ie, technetium Tc 99m, gallium Ga 67, indium In 111 leukocyte scans) are used to nonspecifically localize areas of inflammation. They cannot be used to distinguish infectious from sterile processes. However, they may be of use in diagnosing septic arthritis in relatively sequestered areas, such as the hip and sacroiliac joints.
  • In PJI, plain radiographs can reveal new subperiosteal bone growth and transcortical sinus tracts. These findings are specific for infection. Arthrography can demonstrate loosening of the prosthesis and abscesses. Nuclear scans of all types have limited diagnostic usage in patients with PJI. CT scans are useful in ascertaining the state of the surrounding soft tissue. MRIs are limited by the type of implanted material. This diagnostic modality can safely image only titanium or tantalum devices.

Procedures

  • Always perform joint aspiration under the most sterile conditions possible to prevent the introduction of infection.
  • Obtaining a biopsy of the synovium may be necessary to diagnose one of the many causes (ie, mycobacterial, fungal) of granulomatous synovitis.

Histologic Findings

Examining the synovium histologically often establishes a diagnosis of fungal or mycobacterial joint infections.



Medical Care

Medical management of infective arthritis focuses on adequate and timely drainage of the infected synovial fluid, administration of appropriate antimicrobial therapy, and immobilization of the joint to control pain. Acute PJI ( <3 wk in duration) can be cured medically if it is of the early type or secondary to hematogenous spread without any evidence of periarticular soft tissue involvement or joint instability.

  • Usually, the antibiotic must be administered parenterally for 3-4 weeks, but each case needs to be evaluated individually.
  • Initial antibiotic choices must be empirical, based on the sensitivity pattern of the pathogens of the community. Consider the rise of resistance among potential bacteria when choosing an initial antibiotic regimen. If local incidence of methicillin-resistant S aureus (MRSA) is high (in particular, marked increase in the resistance of the pneumococcus), prescribe alternate antibiotics initially. Because many isolates of group B streptococci have become tolerant of penicillin, use a combination of penicillin and gentamicin or a later generation cephalosporin. MRSA is becoming established outside of the hospital. Enterobacteriaceae and P aeruginosa are becoming more resistant to multiple antibiotics. Knowing the resistance patterns in the community, as well as in the hospital, is most important.
  • Preferably, the antibiotic should be bactericidal with some effect against the slow-growing organisms that are protected within a biofilm such as CONS. Rifampin fulfills these requirements. It should never be used alone because of the rapid development of bacterial resistance to the drug.
  • The choice of the type of drainage, whether percutaneous or surgical, has not been resolved completely. In general, use a needle aspirate initially, repeating joint taps frequently enough to prevent significant reaccumulation of fluid. Aspirating the joint 2-3 times a day may be necessary during the first few days. If frequent drainage is necessary, surgical drainage becomes more attractive.
  • If, after 5 days of therapy, the joint shows some degree of improvement, consider an empirical trial of an anti-inflammatory agent.
  • If the joint fails to respond after 5 days of appropriate antibiotic therapy (eg, presence of clinically significant fever, continued synovial purulence, persistently positive findings on culture), reassess the therapeutic approach.
    • Reculture the fluid and reexamine for crystals.
    • Perform appropriate serologies for diagnosis of Lyme disease.
    • If fungal or mycobacterial infection is possible, consider obtaining a synovial biopsy.
    • Consider the possibility of reactive arthritis. Nonsteroidal inflammatory agents are the primary therapeutic agents for reactive arthritis.
    • Perform imaging studies, either radiographs or an MRI, to rule out periarticular osteomyelitis.

Surgical Care

Surgical drainage is indicated when one or more of the following occur: the appropriate choice of antibiotic and vigorous percutaneous drainage fails to clear the infection after 5-7 days, the infected joints are difficult to aspirate (eg, hip), or adjacent soft tissue is infected.

  • Routine arthroscopic lavage rarely is indicated. However, drainage through the arthroscope is replacing open surgical drainage. With arthroscopic drainage, the operator can visualize the interior of the joint and can drain pus, debride, and lyse adhesions.
  • Gonococcal-infected joints rarely require surgical drainage.
  • In cases of PJI that require surgery for cure (see above), successful treatment requires appropriate antibiotic therapy combined with removal of the hardware. Despite appropriate antibiotic use, the success rate is only about 20% if the prosthesis is left in place. A 2-stage approach is the most effective technique.
    • First, remove the prosthesis and follow with 6 weeks of antibiotic therapy. Then, place the new joint, impregnating the methylmethacrylate cement with an anti-infective agent (ie, gentamicin, tobramycin). Antibiotic diffusion into the surrounding tissues is the goal. The success rate for this approach is approximately 95% for both hip and knee joints.
    • An intermediate method is to exchange the new joint for the infected joint in a 1-stage surgical procedure with concomitant antibiotic therapy. This method, with concurrent use of antibiotic cement, succeeds in 70-90% of cases.

Consultations

In general, request an orthopedic or rheumatology consultation. If initial response is poor or the etiology of the synovitis remains unknown, consult with an infectious disease specialist.

Activity

If the patient's condition responds adequately after 5 days of treatment, begin gentle mobilization of the infected joint. Most patients require aggressive physical therapy to allow maximum postinfection functioning of the joint.



The empirical choice of antibiotic therapy is based on results of the Gram stain and the clinical picture and background of the patient. When the Gram stain fails to reveal any microorganisms (40-50% of cases), the individual's age and sexual activity become the major determinants to differentiate gonococcal from nongonococcal arthritis. When no evidence suggests infection elsewhere, antibiotics must cover S aureus, streptococcal species, and gonococci (in patients who are sexually active).

Evidence shows that earlier initiation of an appropriate antibiotic regimen produces better functional results. Generally, treatment is administered intravenously for 3-4 weeks. The major exception to this is in the case of joints with gonococcal infection, for which total therapy is approximately 2 weeks, with switch to oral therapy. No indication exists for direct installation of antibiotics into the joint cavity. Such practice may increase the degree of inflammation.

Drug Category: Antibiotics

Therapy must be comprehensive and cover all likely pathogens in the context of this clinical setting. The use of linezolid with or without rifampin should be considered for staphylococcal PJI.

Drug NameCeftriaxone (Rocephin)
DescriptionDOC against N gonorrhoeae and effective against gram-negative enteric rods. Monitor sensitivity data.
Adult Dose2 g IV qd for 48 h after clinical improvement, followed by 1 wk PO therapy with cefixime
Pediatric Dose50-75 mg/kg/d IV divided q12h for 4 wk; not to exceed 2 g/d
ContraindicationsDocumented hypersensitivity
InteractionsProbenecid may increase ceftriaxone levels; coadministration with ethacrynic acid, furosemide, and aminoglycosides may increase nephrotoxicity
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsAdjust dose in renal impairment; caution in breastfeeding women; avoid predelivery and in neonates; may cause pseudobiliary lithiasis

Drug NameCiprofloxacin (Cipro)
DescriptionAlternative antibiotic to ceftriaxone to treat N gonorrhoeae and gram-negative enteric rods.
Adult Dose400 mg IV for 48 h after improvement, then 500 mg PO q12h for 1 wk
Pediatric Dose<18 years: Not recommended
>18 years: Administer as in adults
ContraindicationsDocumented hypersensitivity
InteractionsAntacids, iron salts, and zinc salts may reduce serum levels; administer antacids 2-4 h before or after taking fluoroquinolones; cimetidine may interfere with metabolism of fluoroquinolones; ciprofloxacin reduces therapeutic effects of phenytoin; probenecid may increase ciprofloxacin serum concentrations; may increase toxicity of theophylline, caffeine, cyclosporine, and digoxin (monitor digoxin levels); may increase effects of anticoagulants (monitor PT)
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsCaution in pregnancy; adjust dose in renal impairment; superinfections may occur with prolonged or repeated antibiotic therapy; may cause seizures; avoid in patients with seizure and/or CNS disorders

Drug NameCefixime (Suprax)
DescriptionThird-generation oral cephalosporin with broad activity against gram-negative bacteria. By binding to one or more of the penicillin-binding proteins, arrests bacterial cell wall synthesis and inhibits bacterial growth.
PO follow-up to IV ceftriaxone to treat N gonorrhoeae.
Note: After a period of unavailability, oral cefixime is again FDA approved in tab and susp forms. However, at the time of this writing, tabs remain unavailable in the United States. Wyeth Pharmaceuticals (Collegeville, Pa) discontinued manufacturing Suprax in the United States. In October 2002, the company ceased marketing cefixime tab (200 mg and 400 mg) because of depletion of company inventory. Wyeth's patent for cefixime expired on November 10, 2002.
Adult Dose400 mg PO q12h for 1 wk
Pediatric Dose4 mg/kg (elixir) PO q12h for 1 wk
ContraindicationsDocumented hypersensitivity
InteractionsProbenecid may increase effects of cefixime
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsAdjust dose in renal impairment

Drug NameOxacillin (Bactocill)
DescriptionUseful against methicillin-sensitive S aureus.
Adult Dose2 g IV q4h for 4 wk
Pediatric Dose12.5-50 mg/kg IV q6h for 4 wk
ContraindicationsDocumented hypersensitivity
InteractionsOxacillin decreases effects of contraceptives and tetracycline; when administered concomitantly with disulfiram and probenecid, oxacillin levels may increase; effects of anticoagulants increase when large IV doses of oxacillin are administered
PregnancyB - Usually safe but benefits must outweigh the risks.
PrecautionsDecrease dose with impaired renal function

Drug NameVancomycin (Vancocin)
DescriptionAnti-infective against methicillin-sensitive S aureus, methicillin-resistant CONS, and ampicillin-resistant enterococci in patients allergic to penicillin.
Adult Dose15 mg/kg IV q12h, infuse over 60 min; not to exceed 2 g/24 h unless serum levels are monitored
Pediatric Dose10 mg/kg IV q6h for 1 mo
ContraindicationsDocumented hypersensitivity
InteractionsErythema, histaminelike flushing, and anaphylactic reactions may occur when administered with anesthetic agents; when taken concurrently with aminoglycosides, effects on neuromuscular blockade may be enhanced when coadministered with nondepolarizing muscle relaxants
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsCaution in renal failure and neutropenia; too rapid IV infusion (dose administered over a few min) causes red man syndrome; rarely occurs when dose is administered as 2-h administration or as PO or IP administration; red man syndrome is not an allergic reaction

Drug NameLinezolid (Zyvox)
DescriptionAlternative in patients allergic to vancomycin and for treatment of vancomycin-resistant enterococci.
Adult Dose600 mg/kg IV q12h for 1 mo
Pediatric DoseNot established
ContraindicationsDocumented hypersensitivity; MAOI use
InteractionsReduce dose of dopamine or epinephrine if concurrent use required
PregnancyC - Safety for use during pregnancy has not been established.
PrecautionsCaution in patients who are at increased risk for bleeding, have preexisting thrombocytopenia, receive concomitant medications that may decrease platelet count or function, or who may require > 2 wk of therapy (monitor platelet counts)



Further Inpatient Care

  • Usually, immobilization of the infected joint to control pain is not necessary after the first few days.
  • Initial physical therapy consists of maintaining the joint in its functional position and providing passive range of motion exercises. The joint should bear no weight until the clinical signs and symptoms of synovitis have resolved. Aggressive physical therapy often is required to achieve maximum therapy benefit.
  • Overall, the mean length of hospitalization for septic arthritis is 11.5 days. However, outpatient antibiotic therapy in stable patients can significantly reduce hospital stays.

Further Outpatient Care

  • Perform physical therapy as indicated.

In/Out Patient Meds

  • Oral antibiotics usually are used in treating gonococcal joint infections. Antibiotics have a role in suppressing associated chronic osteomyelitis and chronically infected prosthetic material that cannot be removed for various reasons.

Deterrence/Prevention

  • Strictly adhere to sterile procedures whenever the joint space is invaded (eg, in aspiration or arthroscopic procedures).
  • Antibiotic prophylaxis with an antistaphylococcal antibiotic has been demonstrated to reduce wound infections in joint replacement surgery. Polymethylmethacrylate cement impregnated with antibiotics may decrease perioperative infections.
  • Using antibiotic prophylaxis on the same theoretical basis as that for cardiac valvular disease has been advocated. In short, whenever a sustained bacteremia may be encountered, consider using a prophylactic regimen similar to those of the American Heart Association. The implanted hardware most likely is at greatest risk of bacteremia infection within a few months of placement. The risk probably decreases as a pseudocapsule evolves. During this time, prophylaxis probably is most beneficial.
  • Treat any infection promptly to lessen the chance of bloodstream invasion.
  • Decreasing the incidence of underlying infections best prevents reactive arthritis.

Complications

  • Dysfunctional joints, osteomyelitis, and sepsis are complications.

Prognosis

  • Fifty percent of adults with septic arthritis have significant sequelae of decreased range of motion or chronic pain after infection.
  • Predictors of poor outcome in suppurative arthritis include the following:
    • Age older than 60 years
    • Infection of the hip or shoulder joints
    • Underlying rheumatoid arthritis
    • Positive findings on synovial fluid cultures after 7 days of appropriate therapy
    • Delay of 7 days or more in instituting therapy
  • Thirty percent of cases of reactive arthritis may become chronic.

Patient Education

  • Instruct patients with a prosthetic joint in place to recognize early signs of joint infection and, more importantly, to recognize bacterial infections in other parts of their bodies to prevent associated bacteremias.
  • For excellent patient education resources, visit eMedicine's Arthritis Center and Bites and Stings Center. Also, see eMedicine's patient education articles Knee Pain and Ticks.



Medical/Legal Pitfalls

  • Failure to recognize an infected joint and to promptly institute appropriate therapy poses a significant malpractice risk.



  • Aliabadi P, Nikpoor N. Imaging osteomyelitis. Arthritis Rheum. May 1994;37(5):617-22. [Medline].
  • Baraboutis I, Skoutelis A. Streptococcus pneumoniae septic arthritis in adults. Clin Microbiol Infect. Dec 2004;10(12):1037-9. [Medline].
  • Broy SB, Schmid FR. A comparison of medical drainage (needle aspiration) and surgical drainage (arthrotomy or arthroscopy) in the initial treatment of infected joints. Clin Rheum Dis. Aug 1986;12(2):501-22. [Medline].
  • Cucurull E, Espinoza LR. Gonococcal arthritis. Rheum Dis Clin North Am. May 1998;24(2):305-22. [Medline].
  • Garcia-De La Torre I. Advances in the management of septic arthritis. Rheum Dis Clin NA. 2003;29:61-75.
  • Goldenberg DL, Cohen AS. Acute infectious arthritis. A review of patients with nongonococcal joint infections (with emphasis on therapy and prognosis). Am J Med. Mar 1976;60(3):369-77. [Medline].
  • Goldenberg DL. Septic arthritis and otherinfections of rheumatological signifigance. Rheum Clin NA. 1991;17:149. [Medline].
  • Kaandorp CJ, Dinant HJ, van de Laar MA, et al. Incidence and sources of native and prosthetic joint infection: a community based prospective survey. Ann Rheum Dis. Aug 1997;56(8):470-5. [Medline].
  • Kaandorp CJ, Krijnen P, Moens HJ, et al. The outcome of bacterial arthritis: a prospective community-based study. Arthritis Rheum. May 1997;40(5):884-92. [Medline].
  • Manadan AM, Block JA. Daily needle aspiration versus surgical lavage for the treatment of bacterial septic arthritis in adults. Am J Ther. Sep-Oct 2004;11(5):412-5. [Medline].
  • McGuire NM, Kauffman CA. Septic arthritis in the elderly. J Am Geriatr Soc. Mar 1985;33(3):170-4. [Medline].
  • Raad J, Peacock JE Jr. Septic arthritis in the adult caused by Streptococcus pneumoniae: a report of 4 cases and review of the literature. Semin Arthritis Rheum. Oct 2004;34(2):559-69. [Medline].
  • Rosenthal J, Bole GG, Robinson WD. Acute nongonococcal infectious arthritis. Evaluation of risk factors, therapy, and outcome. Arthritis Rheum. Aug 1980;23(8):889-97. [Medline].
  • Ross JJ, Shamsuddin H. Sternoclavicular septic arthritis: review of 180 cases. Medicine (Baltimore). May 2004;83(3):139-48. [Medline].
  • Smith JW, Piercy EA. Infectious arthritis. Clin Infect Dis. Feb 1995;20(2):225-30; quiz 231. [Medline].
  • Steere AC, Levin RE, Molloy PJ, et al. Treatment of Lyme arthritis. Arthritis Rheum. Jun 1994;37(6):878-88. [Medline].
  • Wise CM, Morris CR, Wasilauskas BL, Salzer WL. Gonococcal arthritis in an era of increasing penicillin resistance. Presentations and outcomes in 41 recent cases (1985-1991). Arch Intern Med. Dec 12-26 1994;154(23):2690-5. [Medline].
  • Zimmerli WZ, Trampuz A, Ochsner P. Prosthetic Joint Infections. New Engl J Med. 2004;351:1654.
  • Zimmermann B, Mikolich DJ, Ho G. Septic bursitis. Semin Arthritis Rheum. Jun 1995;24(6):391-410. [Medline].

Septic Arthritis excerpt

Article Last Updated: Oct 18, 2005